Berlin - SPecific Acute Treatment in Ischemic or hAemorrhagic Stroke With Long Term Follow-up

NCT03027453 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15246

Last updated 2022-09-13

No results posted yet for this study

Summary

The B-SPATIAL-Registry will provide a tool of quality assessment for stroke specific Treatments such as endovascular treatment. It will also enable the participating hospitals to compare the quality of care of their facility. At the same time, B-SPATIAL will provide an opportunity of scientific evaluation of new therapeutic procedures or specific treatments in stroke (i.e. reversal of oral anticoagulation in intracerebral hemorrhage or intravenous thrombolysis), not sufficiently investigated so far. Finally, the B-SPATIAL Registry will allow for an identification of key quality indicators that assure valid quality assessment aiming at a reduced documentation load for future quality management.

Conditions

Sponsors & Collaborators

  • Berliner Feuerwehr

    collaborator UNKNOWN
  • Bundeswehrkrankenhaus Berlin

    collaborator OTHER
  • DRK-Kliniken Berlin Köpenick

    collaborator UNKNOWN
  • Evangelisches Krankenhaus Königin Elisabeth Herzberge

    collaborator UNKNOWN
  • Helios Klinikum Berlin-Buch

    collaborator OTHER
  • Jüdisches Krankenhaus Berlin

    collaborator UNKNOWN
  • Park-Klinik Weissensee

    collaborator UNKNOWN
  • Schlosspark-Klinik

    collaborator UNKNOWN
  • Unfallkrankenhaus Berlin

    collaborator OTHER
  • Vivantes Auguste-Viktoria-Klinikum

    collaborator UNKNOWN
  • Vivantes Klinikum im Friedrichshain

    collaborator UNKNOWN
  • Vivantes Humboldt-Klinikum

    collaborator UNKNOWN
  • Vivantes Clinic Neukölln

    collaborator OTHER
  • Vivantes Klinikum Spandau

    collaborator UNKNOWN
  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Jessica L Rohmann · Center for Stroke Research Berlin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2021-04-30
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03027453 on ClinicalTrials.gov